AbCellera Biologics Inc. Shares Outstanding (Cover Page)
AbCellera Biologics Inc. (ABCL) had Shares Outstanding (Cover Page) of 306.61 million shares as of 2026-08-03, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-08-03: Entity Common Stock, Shares Outstanding 306.61M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 305.38M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 303.16M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 299.34M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 306.61M shares 10-Q · filed 2026-08-05 |
| 2026-05-07 | 305.38M shares 10-Q · filed 2026-05-11 |
| 2026-02-19 | 303.16M shares 10-K · filed 2026-02-24 |
| 2025-11-03 | 299.34M shares 10-Q · filed 2025-11-06 |
| 2025-08-04 | 298.83M shares 10-Q · filed 2025-08-07 |
| 2025-05-05 | 298.48M shares 10-Q · filed 2025-05-08 |
| 2025-02-21 | 297.99M shares 10-K · filed 2025-02-27 |
| 2024-10-31 | 295.37M shares 10-Q · filed 2024-11-04 |
| 2024-08-01 | 294.67M shares 10-Q · filed 2024-08-06 |
| 2024-05-01 | 294.05M shares 10-Q · filed 2024-05-07 |
| 2024-02-15 | 292.78M shares 10-K · filed 2024-02-20 |
| 2023-10-30 | 290.17M shares 10-Q · filed 2023-11-02 |
| 2023-07-31 | 289.36M shares 10-Q · filed 2023-08-03 |
| 2023-05-01 | 288.73M shares 10-Q · filed 2023-05-04 |
| 2023-02-17 | 287.69M shares 10-K · filed 2023-02-21 |
| 2022-11-03 | 286.10M shares 10-Q · filed 2022-11-08 |
| 2022-08-04 | 285.14M shares 10-Q · filed 2022-08-09 |
| 2022-05-05 | 284.54M shares 10-Q · filed 2022-05-10 |
| 2022-02-20 | 283.92M shares 10-K/A · filed 2022-07-22 |
| 2021-11-08 | 281.58M shares 10-Q · filed 2021-11-10 |
| 2021-08-10 | 278.70M shares 10-Q · filed 2021-08-13 |
| 2021-05-10 | 270.93M shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |